8-K: Sila Realty Trust Reports Mixed Q4, Full-Year 2025 Results
Quarterly and Annual Results
Sila Realty Trust, a healthcare-focused REIT, announced its fourth quarter and full-year 2025 operating results, highlighting strategic acquisitions amidst a decline in GAAP net income.
Summary
- Net income for the fourth quarter of 2025 was $5.0 million, or $0.09 per diluted share, compared to $11.1 million, or $0.20 per diluted share, for Q4 2024.
- Cash net operating income (Cash NOI) for Q4 2025 was $44.0 million, an increase from $41.0 million in Q4 2024.
- Adjusted funds from operations (AFFO) for Q4 2025 was $30.4 million, or $0.55 per diluted share, a slight increase from $30.2 million, or $0.54 per diluted share, in Q4 2024.
- Full-year 2025 net income was $33.1 million, or $0.60 per diluted share, down from $42.7 million, or $0.75 per diluted share, for the full-year 2024.
- Full-year 2025 Cash NOI was $169.9 million, up from $168.6 million in 2024, driven by acquisitions and same-store Cash NOI growth of 0.9%.
- Full-year 2025 AFFO was $120.9 million, or $2.18 per diluted share, a decrease from $131.1 million, or $2.31 per diluted share, in 2024.
- Acquired six operating healthcare properties in 2025, totaling approximately 241,000 rentable square feet, for an aggregate purchase price of $148.9 million.
- Fully funded two mezzanine loans totaling $17.5 million for the development of an inpatient rehabilitation facility and a behavioral healthcare facility.
- Declared a quarterly cash dividend of $0.40 per share, payable on March 18, 2026, to stockholders of record as of March 6, 2026.
- Subsequent to year-end, acquired one inpatient rehabilitation facility for $43.1 million on January 15, 2026, and sold the Saginaw Healthcare Facility for $14.5 million on January 29, 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a mixed report. While the company demonstrates strong operational metrics like Cash NOI growth and a robust balance sheet, the decline in GAAP net income and full-year AFFO, coupled with rising interest expenses, presents a cautious outlook despite strategic acquisitions.
Positives
- Cash NOI increased to $44.0 million in Q4 2025 (from $41.0 million in Q4 2024) and to $169.9 million for the full-year 2025 (from $168.6 million in 2024), driven by acquisitions and same-store growth (0.7% in Q4, 0.9% for the year).
- Successfully acquired six high-quality healthcare properties for approximately $149 million in 2025, expanding the portfolio.
- Fully funded two mezzanine loans totaling $17.5 million for new facility developments, indicating strategic investment in growth.
- Maintained a high portfolio leased rate of 98.7% as of December 31, 2025, demonstrating strong tenant retention.
- The weighted average remaining lease term is a robust 10.0 years, providing predictable income streams.
- Reported a strong balance sheet with approximately $481.3 million in liquidity as of December 31, 2025.
- Maintained a low net debt to annualized EBITDAre ratio of 3.9x, indicating prudent leverage management.
- High EBITDARM rent coverage ratios provide continued confidence in the strength and sustainability of income streams.
- A consistent quarterly cash dividend of $0.40 per share was declared, representing an annualized amount of $1.60 per share.
Negatives
- GAAP net income decreased significantly for Q4 2025 to $5.0 million from $11.1 million in Q4 2024.
- Full-year 2025 GAAP net income decreased to $33.1 million from $42.7 million in 2024.
- Diluted EPS decreased for Q4 2025 to $0.09 from $0.20 in Q4 2024, and for the full-year 2025 to $0.60 from $0.75 in 2024.
- Full-year 2025 AFFO decreased to $120.9 million from $131.1 million in 2024.
- Interest expense increased substantially for Q4 2025 to $9.162 million from $5.265 million in Q4 2024, and for the full-year 2025 to $32.786 million from $21.220 million in 2024.
- Impairment and disposition losses increased for the full-year 2025 to $9.951 million from $1.210 million in 2024.
- A 0.4 percentage point decrease in the percentage of square feet leased from Q3 2025 to Q4 2025, primarily due to the expiration of a 15,600 rentable square foot lease.
Risks
- Forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations, including those detailed in the 2024 Annual Report on Form 10-K.
- Cash NOI growth was partially offset by the impact of the Steward Health Care System LLC bankruptcy, specifically concerning the Stoughton Healthcare Facility.
Future Outlook
Management expresses continued confidence in the strength, sustainability, and predictability of income streams, supported by high EBITDARM rent coverage ratios and a long weighted average remaining lease term of 10 years. The company's strong liquidity of almost $500 million and low net debt to annualized EBITDAre ratio of 3.9x are expected to position it to capitalize on high-quality investment opportunities in necessity-based healthcare real estate in 2026 and beyond, while maintaining a thoughtful and disciplined investment approach.
Management Comments
- "The Sila team's prowess in allocating capital was on full display in 2025."
- "We successfully acquired six high quality healthcare properties for approximately $149 million, all of which play a critical role in the social infrastructure of their respective patient communities."
- "Our portfolio's performance in 2025 demonstrates the strength of Sila's proactive asset management capabilities, evidenced by successful rent collections, high tenant lease renewal rates, and new capital allocations for existing property expansions that have clear tenant operational needs."
- "Our high EBITDARM rent coverage ratios and a long weighted average remaining lease term of 10-years provide us with continued confidence in the strength, sustainability, and predictability of our income streams."
- "As we look forward to 2026 and beyond, our liquidity of almost $500 million and low net debt to annualized EBITDAre ratio of 3.9x, position Sila to take advantage of high quality opportunities as they may arise, while remaining thoughtful and disciplined in our approach to investing in necessity based healthcare real estate."
Industry Context
StockSavvy.ai notes that Sila Realty Trust's strategic focus on the healthcare sector aligns with broader industry trends emphasizing resilient, necessity-based real estate. The continued acquisitions and development loans in this sector reflect confidence in its long-term growth drivers, such as an aging population and increasing demand for medical services, positioning the REIT favorably amidst economic fluctuations. The net lease structure further provides stable income streams, a key attraction for investors in the current market environment.
Comparison to Industry Standards
- The company explicitly states that its definitions and calculations of non-GAAP financial measures such as FFO, Core FFO, and AFFO may not be the same as similar measures reported by other REITs, making direct comparisons less meaningful.
Stakeholder Impact
- Shareholders: Will receive a consistent quarterly dividend of $0.40 per share. The decline in GAAP net income and full-year AFFO may raise concerns, but strategic acquisitions and strong operational metrics like Cash NOI growth could support long-term value.
- Tenants: Benefit from proactive asset management and capital allocations for existing property expansions, indicating a supportive landlord relationship.
- Creditors: The strong balance sheet, low net debt to annualized EBITDAre ratio (3.9x), and significant liquidity ($481.3 million) suggest a healthy financial position and ability to service debt.
Next Steps
- Quarterly cash dividend of $0.40 per share payable on March 18, 2026, to stockholders of record as of March 6, 2026.
- A conference call and audio webcast for investors and analysts will be held on Wednesday, February 25, 2026, at 11:00 a.m. Eastern Time to discuss operating results and answer questions.
- The archived webcast will be available for 12 months following the call.
- Continued pursuit of high-quality investment opportunities in necessity-based healthcare real estate in 2026 and beyond.
Key Dates
| Date | Description |
|---|---|
| December 23, 2014 | Acquisition date of Stoughton Healthcare Facility. |
| March 3, 2025 | Filing date of the Company's 2024 Annual Report on Form 10-K with the SEC. |
| March 4, 2025 | Acquisition of Knoxville Healthcare Facility. |
| April 16, 2025 | Acquisition of Dover Healthcare Facility. |
| August 1, 2025 | Acquisition of Southlake Healthcare Facility and Southlake Healthcare Facility II. |
| September 5, 2025 | Acquisition of Plano Healthcare Facility and Peoria Healthcare Facility. |
| December 31, 2025 | End of the fourth quarter and full fiscal year for which results are reported. |
| January 15, 2026 | Acquisition of one inpatient rehabilitation facility in Oklahoma City. |
| January 29, 2026 | Sale of the Saginaw Healthcare Facility. |
| February 23, 2026 | Board authorized a quarterly cash dividend of $0.40 per share. |
| February 24, 2026 | Date of earliest event reported and filing date of the Current Report on Form 8-K. |
| February 25, 2026 | Conference call and audio webcast for investors and analysts to discuss Q4 and full-year 2025 operating results. |
| March 6, 2026 | Record date for the quarterly cash dividend. |
| March 18, 2026 | Payment date for the quarterly cash dividend. |
| November 5, 2029 | Maturity date for the two mezzanine loans. |
Recommendation
holdWhile Sila Realty Trust demonstrates operational strength with growing Cash NOI, a high occupancy rate, and a disciplined acquisition strategy in the resilient healthcare sector, the notable declines in GAAP net income and full-year AFFO, alongside rising interest expenses, warrant a cautious stance. The company's strong liquidity and low leverage are positives, but the overall financial performance for the year suggests a 'hold' as investors assess if the strategic growth can translate into improved bottom-line GAAP metrics in future periods.
Keywords
Healthcare REIT, Net Lease, Real Estate, Sila Realty Trust, Financial Results, Q4 2025, Full Year 2025, Acquisitions, Dividends, Corporate Earnings, REIT, Commercial Real Estate
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.